Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Illumina, Inc. (ILMN) vs iShares 1 3 Year Treasury Bond ETF (SHY) Price & Performance

Illumina, Inc.Trade
iShares 1 3 Year Treasury Bond ETFTrade

Price performance (Past 24H)

Key statistics

Illumina, Inc. vs iShares 1 3 Year Treasury Bond ETF — how do they compare? Illumina, Inc. trades at $278.17 (market cap $39.95B), while iShares 1 3 Year Treasury Bond ETF trades at $81.2 (market cap $26.68B). The key difference: Illumina, Inc. is the larger of the two by market cap, and Illumina, Inc. is trading nearer its 52-week high, iShares 1 3 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and iShares 1 3 Year Treasury Bond ETF for 63 Days on average.

ILMNSHY
Market Cap
$39.95B$26.68B
Volume
3,169,5034,077,691
Sector
HealthFixed Income
52-Week High
$293.69$83.18
52-Week Low
$91.00$81.05
Typical Hold Time
83 Days63 Days
Enterprise Value
$41.31B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Illumina, Inc.

Illumina (ILMN) trades at $264.40, down 1.25% on the day but remains near its 52-week high of $278.99, reflecting strong momentum with a 94.9% YTD gain. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Fundamentals show a significant turnaround, with net income reaching $850 million in 2025 after prior losses, supported by robust gross margins of 66.38%. Technical indicators are bullish overall, with key support at $257 and resistance at $268.

The outlook for ILMN is positive, driven by earnings momentum, inclusion in the S&P 500, and strategic AI initiatives in genomics. However, risks include high valuation multiples, such as a P/E of 49.36, and potential margin pressure from cost volatility. Analyst consensus is bullish with a 54% buy rating, though the consensus price target of $241 suggests limited near-term upside from current levels.

iShares 1 3 Year Treasury Bond ETF

SHY trades at $81.20 with minimal daily movement (+0.05%), reflecting stability amid broader bond market volatility. Technical indicators show a bearish trend with moving averages signaling caution, while oscillators remain neutral. Recent dividend payments of $0.24-$0.25 per share provide income stability, though key financial ratios are unavailable for fundamental assessment. The bond ETF faces headwinds from rising Treasury yields and inflation concerns.

Outlook remains cautious as rising interest rates pressure bond ETFs, though SHY's short-term focus may offer relative safety. Key risks include prolonged high yields and economic uncertainty. Investment appeal hinges on income generation in a volatile rate environment, with technical weakness suggesting limited near-term upside.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ILMN

No sentiment data available yet.

SHY
100% Buy0% Sell
Avg holding period · 63 Days

Top news

Latest headlines on both assets

About Illumina, Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Read more on ILMN →

About iShares 1 3 Year Treasury Bond ETF

SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.

Read more on SHY →